Outcome of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced grade 1/2 pancreatic neuroendocrine tumours - Ezziddin, S; Khalaf, F; Vanezi, M (Eur J Nucl Med Mol Imaging, 2014)
, et al.